Viva Biotech Holdings (VBIZF)
OTCMKTS · Delayed Price · Currency is USD
0.1850
0.00 (0.00%)
At close: Aug 4, 2025
Augmedix Market Cap
Viva Biotech Holdings has a market cap or net worth of $440.57 million as of August 6, 2025. Its market cap has increased by 221.13% in one year.
Market Cap
440.57M
Enterprise Value
488.88M
Revenue
272.18M
Ranking
n/a
PE Ratio
19.22
Stock Price
$0.19
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 844.70M to 440.57M, a decrease of -47.84%. That is a compound annual growth rate of -9.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 440.57M | 88.31% |
| Dec 31, 2024 | 233.96M | -18.73% |
| Dec 29, 2023 | 287.88M | -33.04% |
| Dec 30, 2022 | 429.89M | -62.94% |
| Dec 31, 2021 | 1.16B | -48.59% |
| Dec 31, 2020 | 2.26B | 146.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.48M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.60M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.46M |